Are you responsible for New Chemical Entity Development? Or just Reducing Toxicity levels later on? Then you will be aware that the majority of drugs fail to make it to market due to increase toxicity levels. Reducing Toxicity in Drug Compound, London, Thistle Marble Arch, 26th-27th January, will enable drug discovery scientists, to analyse results and implement testing at a much earlier stage to limit cost and employ techniques to correctly identify lower toxic entities for further drug development.
2) Benefits for attending

Gain essential insight of how you can help towards designing out toxicity working towards minimising research costs

Decrease time to market by benchmarking your latest strategies against those in the leading pharmaceutical industry

Employ toxicity modelling techniques to ensure accuracy in predictive methods to improve your ROI

3) Who will attend?

• Medicinal Chemists
• Drug Safety Researchers
• Pre Clinical Development
• Toxicologists
• Analytical Chemists
• Drug Discovery
• Formulation Scientists

Reducing Toxicity in Drug Compound, London, Thistle Marble Arch, 26th-27th January Contact us on 0800 652 2363 or +44 (0) 20 7368 9300 or email enquire@iqpc.co.uk